Patents
RNA interference-based therapeutics company granted patent
Published in Hepatitis Weekly, April 4th, 2005
The first patent, titled "Composition and Method for In Vivo and In Vitro Attenuation of Gene Expression Using Double-Stranded RNA" (AU patent No. 776150), covers the use of synthetically produced as well as DNA-encoded double-stranded RNA in vertebrates for attenuation of gene expression (RNA interference). The claims cover the use of RNAi in vertebrate cell culture and animals, as well as RNAi-based human therapeutics.
The second patent, titled "Composition and Method for In Vivo and In Vitro...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-04-04)
More Articles from Hepatitis Weekly
- Antiviral Therapy
Acylated peptides battle hepatitis B virus infection - Chronic Liver Disease
Patients with bleeding disorders can safely undergo transjugular liver biopsy - Hepatitis
Osteopontin marks liver damage in patients with fulminant hepatitis - Neuroscience
EEG values change with age in patients receiving interferon for hepatitis C - Virology
Apoptosis markers trace histological activity in viral hepatitis patients - Adverse Drug Reaction
Rituximab ameliorates interferon-related thrombocytopenia - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
